Sign in
Taking people in United StatesPhase 3

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Key facts

Who runs it
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Where
Albuquerque, Allen Park, Annapolis, Anniston, Atlanta, Boise, Bountiful, Boynton Beach, Bridgeport, Brooklyn, Burlington, Carlsbad, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Clarkston, Clearwater, Cleveland, Columbus, Cortland, Cullman, Dallas, Dayton, Dearborn, DeLand, Denver, Duncansville, Durham, Edmond, Erie, Farmington Hills, Fort Collins, Fort Lauderdale, Fremont, Fullerton, Garden Grove, Glendale, Greenville, Gulfport, Hartsdale, Henderson, Hendersonville, Horsham, Houston, Hutchinson, Jupiter, Kansas City, La Mesa, Lake Charles, Lakewood, Laredo, Las Vegas, Lenexa, Lewisville, Long Beach, Longmont, Louisville, Mankato, McAllen, Melrose Park, Meridian, Mesa, Miami, Miami Lakes, Middleburg Heights, Missoula, Modesto, Monroe, Morehead City, New Orleans, New Port Richey, Newton, North Las Vegas, North Miami, Northridge, Oceanside, Oklahoma City, Omaha, Orlando, Palos Heights, Pasadena, Pearland, Phoenix, Plano, Port Orange, Port Saint Lucie, Prairieville, Redding, Renton, Richmond, Rochester, Salisbury, Salt Lake City, San Antonio, San Diego, Silver Spring, Southfield, Spartanburg, Springfield, St Louis, St. Petersburg, Stamford, Stockbridge, Tempe, The Bronx, Tucson, Tulsa, Valparaiso, Walnut Creek, Warren Township, Washington D.C., West Des Moines, West Palm Beach, Wilmington, Winston-Salem, Winter Park, and Yukon, United StatesSee the 135 sitesAlso in 5 other countries, 76 sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
10,000 people, planned
Started
25 Sept 2025
Expected to end
2 Jul 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • MK-1406
  • Placebo
Record updated
13 November 2026

Who can take part

Age
12 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 26 criteriaShow less

Who can take part

  • The main inclusion criteria include but are not limited to the following:
  • Primary Stratum A (non-immunocompromised participants who have chronic stable medical conditions) and Primary Stratum B (participants who are immunocompromised either due to underlying disease or receipt of immunosuppressive medications)
  • Has negative rapid antigen tests for influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prior to dosing at Day 1
  • Weight is ≥ 40 kg; Primary Stratum A only
  • Has a history of pulmonary disease
  • Has moderate to severe asthma, as defined by the Global Initiative for Asthma (GINA 2025)
  • Has existing cardiac disease
  • Has insulin-dependent diabetes
  • Has moderate renal impairment
  • Is ≥ 65 years of age at the time of randomization but does not meet any of the above criteria for Primary Stratum A, and is otherwise healthy; Primary Stratum B only
  • Has a solid tumor diagnosis AND has received chemotherapy and/or immunotherapy within 1 year of screening
  • Has a diagnosis of a hematologic malignancy within 5 years of screening AND has received any chemotherapy or biologic therapy within 1 year of screening
  • Participants who have had a solid organ transplant (SOT) must satisfy all of the following:; Has received a kidney, liver, heart, or lung transplant more than 6 months prior to screening; Is currently receiving at least two immunosuppressive medications
  • Participants who have had a hematopoietic stem cell transplant (HSCT) must satisfy at least one of the following:; Has a history of hematopoietic stem cell transplantation (HSCT) (i.e., autologous, allogeneic, bone marrow, peripheral blood stem cell, tandem [peripheral blood and marrow]) within 1 year of screening; Has a history of non-autologous HSCT with graft-versus-host disease (GvHD) requiring active treatment with immunosuppressants (e.g., systemic corticosteroids ≥1 mg/kg at screening), regardless of the duration of time since HSCT
  • Is receiving immunosuppressive medicines
  • Has received chimeric antigen receptor-modified T-cell therapy
  • Has received B-cell depleting therapies (e.g., rituximab, ocrelizumab, ofatumumab, alemtuzumab) within the 12 months prior to screening
  • Has a diagnosis of any primary immunodeficiency except immunoglobulin A (IgA) deficiency
  • Has advanced or untreated human immunodeficiency virus (HIV) infection

Who cannot take part

  • Has an acute (time-limited) or febrile (temperature ≥ 38.0°C [≥ 100.4°F]) illness within 7 days prior to planned dosing on Day 1
  • Has severe chronic kidney disease (CKD) or is receiving hemodialysis
  • Receipt within the past 30 days or 5 half-lives (whichever is longer) or anticipated receipt of any drug or other biologic agent (e.g., mAbs) administered for the prevention or treatment of influenza
  • Has previously enrolled in this study (CD388.SQ.3.06)
  • Known or suspected allergy or history of anaphylaxis or other serious adverse reactions to zanamivir (following administration of inhaled or intravenous formulations), monoclonal antibody (mAbs (including Fc domains)), or any of the components of CD388 or placebo
  • Has a clinically significant bleeding disorder (e.g., factor deficiency, coagulopathy, or platelet disorder) or medical history of significant bleeding or bruising following intramuscular or subcutaneous (SC) injections or venipuncture
  • The main exclusion criteria include but are not limited to the following:

Where in United States

Also in 5 other countries, 76 sites

  • DM Clinical Research (Site 0731)Albuquerque, United StatesContact: Study CoordinatorTaking people
  • Michigan Institute of Research (MIR) (Site 0734)Allen Park, United StatesContact: Study CoordinatorTaking people
  • Annapolis Internal Medicine - CCT Research (Site 0580)Annapolis, United StatesContact: Study CoordinatorTaking people
  • Pinnacle Research Group (Site 0505)Anniston, United StatesContact: Study CoordinatorTaking people
  • Agile Clinical Research Trials, LLC (Site 0600)Atlanta, United StatesContact: Study CoordinatorTaking people
  • DelRicht Research (Site 0583)Atlanta, United StatesContact: Study CoordinatorTaking people
  • Paradigm Clinical Research - Boise (Site 0614)Boise, United StatesContact: Study CoordinatorTaking people
  • Cope Family Medicine / CCT Research (Site 0602)Bountiful, United StatesContact: Toll Free NumberNo longer taking part
  • Imagine Research of Palm Beach County (Site 0509)Boynton Beach, United StatesContact: Toll Free NumberNo longer taking part
  • New England Research Associates, LLC (Site 0558)Bridgeport, United StatesContact: Study CoordinatorTaking people
  • DM Clinical Research - Brooklyn (Site 0550)Brooklyn, United StatesContact: Study CoordinatorTaking people
  • Skylight Health Research, Inc (Site 0609)Burlington, United StatesContact: Study CoordinatorTaking people
  • Profound Research LLC (Site 0743)Carlsbad, United StatesContact: Study CoordinatorTaking people
  • DelRicht Research (Site 0619)Charleston, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0593)Charlotte, United StatesContact: Toll Free NumberNo longer taking part
  • Charlottesville Medical Research (Site 0559)Charlottesville, United StatesContact: Study CoordinatorTaking people
  • Great Lakes Clinical Trials - Ravenswood (Site 0564)Chicago, United StatesContact: Study CoordinatorTaking people
  • Velocity Clinical Research, Springdale (Site 0511)Cincinnati, United StatesContact: Toll Free NumberNo longer taking part
  • Profound Research LLC (Site 0536)Clarkston, United StatesContact: Toll Free NumberNo longer taking part
  • Innovative Research of West Florida (Site 0596)Clearwater, United StatesContact: Toll Free NumberNo longer taking part
  • Velocity Clinical Research- Cleveland (Site 0520)Cleveland, United StatesContact: Toll Free NumberNo longer taking part
  • Centricity Research Columbus Ohio Multispecialty (Site 0562)Columbus, United StatesContact: Toll Free NumberNo longer taking part
  • Certified Research Associates (Site 0552)Cortland, United StatesContact: Toll Free NumberNo longer taking part
  • Cullman Clinical Trials (Site 0538)Cullman, United StatesContact: Study CoordinatorTaking people
  • DCT-HCWC, LLC dba Discovery Clinical Trials (Site 0606)Dallas, United StatesContact: Study CoordinatorTaking people
  • Lonestar Clinical Research - Dallas (Site 0501)Dallas, United StatesContact: Toll Free NumberNo longer taking part
  • Zenos Clinical Research (Site 0537)Dallas, United StatesContact: Toll Free NumberNo longer taking part
  • PriMED Clinical Research (Site 0560)Dayton, United StatesContact: Study CoordinatorTaking people
  • Michigan Hematology & Oncology Consultants (Site 0610)Dearborn, United StatesContact: Study CoordinatorTaking people
  • Hillcrest Medical Research (Site 0563)DeLand, United StatesContact: Toll Free NumberNo longer taking part
  • Tekton Research (Site 0611)Denver, United StatesContact: Study CoordinatorTaking people
  • Altoona Center for Clinical Research (Site 0545)Duncansville, United StatesContact: Toll Free NumberNo longer taking part
  • Eximia EquiHealth Research (Site 0590)Durham, United StatesContact: Toll Free NumberNo longer taking part
  • Tekton Research, LLC. (Site 0601)Edmond, United StatesContact: Study CoordinatorTaking people
  • Liberty Family Practice (Site 0546)Erie, United StatesContact: Study CoordinatorTaking people
  • Michigan Heathcare Professionals- TRIATRIA (Site 0513)Farmington Hills, United StatesContact: Toll Free NumberNo longer taking part
  • Tekton Research (Site 0613)Fort Collins, United StatesContact: Toll Free NumberNo longer taking part
  • The Oncology Institute of Hope and Innovation - Fort Lauderdale (Site 0728)Fort Lauderdale, United StatesContact: Study CoordinatorTaking people
  • Methodist Physicians Clinic/CCT Research (Site 0598)Fremont, United StatesContact: Study CoordinatorTaking people
  • Triallogix Medical Corporation (Site 0615)Fullerton, United StatesContact: Study CoordinatorTaking people
  • National Institute of Clinical Research (Site 0582)Garden Grove, United StatesContact: Toll Free NumberNo longer taking part
  • Hope Research Institute (Site 0575)Glendale, United StatesContact: Study CoordinatorTaking people
  • Tribe Clinical Research, LLC (Site 0577)Greenville, United StatesContact: Study CoordinatorTaking people
  • DelRicht Research (Site 0584)Gulfport, United StatesContact: Toll Free NumberNo longer taking part
  • Drug Trials America (Site 0553)Hartsdale, United StatesContact: Toll Free NumberNo longer taking part
  • Henderson Clinical Trials (Site 0522)Henderson, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0620)Hendersonville, United StatesContact: Toll Free NumberNo longer taking part
  • Hatboro Medical Associates (Site 0551)Horsham, United StatesContact: Toll Free NumberNo longer taking part
  • Elevate Clinical Research - Houston (Site 0589)Houston, United StatesContact: Study CoordinatorTaking people
  • DM Clinical Research (Site 0503)Houston, United StatesContact: Toll Free NumberNo longer taking part
  • Hutchinson Clinic, P.A. (Site 0729)Hutchinson, United StatesContact: Study CoordinatorTaking people
  • Health Awareness, Inc. (Site 0524)Jupiter, United StatesContact: Study CoordinatorTaking people
  • Clay- Platte Family Medicine, P.C.-CCT Research (Site 0517)Kansas City, United StatesContact: Toll Free NumberNo longer taking part
  • Eximia Clinical Research (Site 0571)La Mesa, United StatesContact: Toll Free NumberNo longer taking part
  • Elevate Clinical Research (Site 0565)Lake Charles, United StatesContact: Toll Free NumberNo longer taking part
  • Critical Care Pulmonary & Sleep Associates - CCT Research (Site 0525)Lakewood, United StatesContact: Study CoordinatorTaking people
  • Laguna Clinical Research Associates LLC (Site 0581)Laredo, United StatesContact: Toll Free NumberNo longer taking part
  • Excel Clinical Research, LLC (Site 0566)Las Vegas, United StatesContact: Study CoordinatorTaking people
  • Santa Rosa Medical Centers of Nevada / CCT Research (Site 0605)Las Vegas, United StatesContact: Study CoordinatorTaking people
  • Johnson County Clin-Trials (Site 0530)Lenexa, United StatesContact: Study CoordinatorTaking people
  • Epic Clinical Research (Site 0578)Lewisville, United StatesContact: Toll Free NumberNo longer taking part
  • Long Beach Clinical Trials, LLC (Site 0607)Long Beach, United StatesContact: Toll Free NumberNo longer taking part
  • Tekton Research, LLC. (Site 0616)Longmont, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0585)Louisville, United StatesContact: Toll Free NumberNo longer taking part
  • Mankato Clinic (Site 0573)Mankato, United StatesContact: Study CoordinatorTaking people
  • Elevate Clinical Research - McAllen (Site 0621)McAllen, United StatesContact: Toll Free NumberNo longer taking part
  • DM Clinical Research (Site 0736)Melrose Park, United StatesContact: Study CoordinatorTaking people
  • Velocity Clinical Research, Boise (Site 0535)Meridian, United StatesContact: Study CoordinatorTaking people
  • Desert Clinical Research/ CCT Research (Site 0612)Mesa, United StatesContact: Toll Free NumberNo longer taking part
  • Hope Research Network-Miami (Site 0742)Miami, United StatesContact: Study CoordinatorTaking people
  • Clinical Site Partners, LLC d/b/a CSP Miami (Site 0521)Miami, United StatesContact: Toll Free NumberNo longer taking part
  • Columbus Clinical Services (Site 0588)Miami, United StatesContact: Toll Free NumberNo longer taking part
  • South Florida Research Center, Inc (Site 0507)Miami, United StatesContact: Toll Free NumberNo longer taking part
  • Floridian Clinical Research, LLC (Site 0534)Miami Lakes, United StatesContact: Study CoordinatorTaking people
  • Indago Research and Health Center Inc (Site 0725)Miami Lakes, United StatesContact: Study CoordinatorTaking people
  • Helios Clinical Research - CLE (Site 0740)Middleburg Heights, United StatesContact: Study CoordinatorTaking people
  • Montana Medical Research, Inc. (Site 0570)Missoula, United StatesContact: Toll Free NumberNo longer taking part
  • Paradigm Clinical Research, LLC (Site 0733)Modesto, United StatesContact: Study CoordinatorTaking people
  • Monroe Biomedical Research (Site 0549)Monroe, United StatesContact: Toll Free NumberNo longer taking part
  • West Clinical Research (Site 0542)Morehead City, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0510)New Orleans, United StatesContact: Toll Free NumberNo longer taking part
  • Suncoast Clinical Research (Site 0724)New Port Richey, United StatesContact: Study CoordinatorTaking people
  • Alliance for Multispecialty Research, LLC (Site 0561)Newton, United StatesContact: Study CoordinatorTaking people
  • Las Vegas Clinical Trials (Site 0527)North Las Vegas, United StatesContact: Toll Free NumberNo longer taking part
  • Behavioral Clinical Research, Inc. (Site 0508)North Miami, United StatesContact: Toll Free NumberNo longer taking part
  • Valley Clinical Trials Inc. (Site 0741)Northridge, United StatesContact: Study CoordinatorTaking people
  • Profound Research LLC (Site 0533)Oceanside, United StatesContact: Toll Free NumberNo longer taking part
  • Lynn Health Science Institute - East (OKC) (Site 0544)Oklahoma City, United StatesContact: Toll Free NumberNo longer taking part
  • Midwest Regional Health Services, LLC / Avacare (Site 0603)Omaha, United StatesContact: Study CoordinatorTaking people
  • Velocity Clinical Research, Omaha (Site 0512)Omaha, United StatesContact: Toll Free NumberNo longer taking part
  • Clinical Neuroscience Solutions (Site 0623)Orlando, United StatesContact: Toll Free NumberNo longer taking part
  • DM Clinical Research (Site 0502)Palos Heights, United StatesContact: Study CoordinatorTaking people
  • Profound Research LLC (Site 0574)Pasadena, United StatesContact: Study CoordinatorTaking people
  • Pearland Physicians (Site 0592)Pearland, United StatesContact: Toll Free NumberNo longer taking part
  • Foothills Research Center (Site 0591)Phoenix, United StatesContact: Toll Free NumberNo longer taking part
  • Research Your Health (Site 0567)Plano, United StatesContact: Study CoordinatorTaking people
  • Javara - Privia Medical Group North Texas - Dallas (Site 0519)Plano, United StatesContact: Toll Free NumberNo longer taking part
  • Progressive Medical Research (Site 0579)Port Orange, United StatesContact: Study CoordinatorTaking people
  • Health Awareness, Inc. (Site 0541)Port Saint Lucie, United StatesContact: Study CoordinatorTaking people
  • DelRicht Research (Site 0594)Prairieville, United StatesContact: Study CoordinatorTaking people
  • Paradigm Clinical Research Centers, Inc (Site 0518)Redding, United StatesContact: Study CoordinatorTaking people
  • Rainier Clinical Research Center (Site 0556)Renton, United StatesContact: Toll Free NumberNo longer taking part
  • Clinical Research Partners, LLC. (Site 0504)Richmond, United StatesContact: Study CoordinatorTaking people
  • Rochester Clinical Research, Inc. (Site 0557)Rochester, United StatesContact: Toll Free NumberNo longer taking part
  • OnSite Clinical Solutions (Site 0608)Salisbury, United StatesContact: Toll Free NumberNo longer taking part
  • Olympus Family Medicine/CCT Research (Site 0604)Salt Lake City, United StatesContact: Toll Free NumberNo longer taking part
  • Clinical Trials of Texas, LLC (Site 0532)San Antonio, United StatesContact: Toll Free NumberNo longer taking part
  • Profound Research LLC (Site 0744)San Diego, United StatesContact: Study CoordinatorTaking people
  • Acclaim Clinical Research (Site 0506)San Diego, United StatesContact: Toll Free NumberNo longer taking part
  • Artemis Institute for Clinical Research (Site 0617)San Diego, United StatesContact: Toll Free NumberNo longer taking part
  • Jadestone Clinical Research, LLC (Site 0555)Silver Spring, United StatesContact: Toll Free NumberNo longer taking part
  • DM Clinical Research (Site 0739)Southfield, United StatesContact: Study CoordinatorTaking people
  • Spartanburg Medical Research (Site 0514)Spartanburg, United StatesContact: Study CoordinatorTaking people
  • Velocity Clinical Research, Spartanburg (Site 0523)Spartanburg, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0586)Springfield, United StatesContact: Toll Free NumberNo longer taking part
  • Sundance Clinical Research LLC (Site 0526)St Louis, United StatesContact: Study CoordinatorTaking people
  • GCP- Global Clinical Research Professionals, LLC (Site 0595)St. Petersburg, United StatesContact: Study CoordinatorTaking people
  • Stamford Therapeutics Consortium (Site 0539)Stamford, United StatesContact: Toll Free NumberNo longer taking part
  • Clinical Research Atlanta (Site 0531)Stockbridge, United StatesContact: Study CoordinatorTaking people
  • Hope Research Institute (Site 0587)Tempe, United StatesContact: Study CoordinatorTaking people
  • Fiel Family and Sports Medicine, PC/CCT Research (Site 0529)Tempe, United StatesContact: Toll Free NumberNo longer taking part
  • CHEAR Center LLC (Site 0543)The Bronx, United StatesContact: Toll Free NumberNo longer taking part
  • Del Sol Research Management, LLC (Site 0515)Tucson, United StatesContact: Study CoordinatorTaking people
  • Arizona Liver Health (Site 0516)Tucson, United StatesContact: Toll Free NumberNo longer taking part
  • DelRicht Research (Site 0618)Tulsa, United StatesContact: Study CoordinatorTaking people
  • Velocity Clinical Research (Site 0528)Valparaiso, United StatesContact: Toll Free NumberNo longer taking part
  • Diablo Clinical Research, Inc. (Site 0572)Walnut Creek, United StatesContact: Toll Free NumberNo longer taking part
  • IMA Clinical Research (Site 0599)Warren Township, United StatesContact: Toll Free NumberNo longer taking part
  • Emerson Clinical Research Institute (Site 0547)Washington D.C., United StatesContact: Toll Free NumberNo longer taking part
  • Integrated Clinical Trial Services, Inc (Site 0576)West Des Moines, United StatesContact: Study CoordinatorTaking people
  • Triple O Research Institute, P.A (Site 0727)West Palm Beach, United StatesContact: Study CoordinatorTaking people
  • Wilmington Health Associates (Site 0548)Wilmington, United StatesContact: Study CoordinatorTaking people
  • Wake Forest University Health Sciences (Site 0569)Winston-Salem, United StatesContact: Study CoordinatorTaking people
  • Clinical Site Partners, LLC dba Flourish Research (Site 0540)Winter Park, United StatesContact: Study CoordinatorTaking people
  • Tekton Research, Inc. (Site 0597)Yukon, United StatesContact: Toll Free NumberNo longer taking part

About the trial

What the trial wants to find out

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000 deaths per year (WHO 2025). Yearly administration of an influenza vaccine for the prevention of influenza is currently recommended. However, the real-world vaccine effectiveness varied from 10% to 60% in the general population across the years of 2004 to 2024, with effectiveness in most years below 50% (CDC 2025) and decreasing to as low as 5% in immunocompromised individuals (Hughes 2021).

Read full original descriptionShow less

The goal of this study is to learn whether MK-1406 (CD388) can help prevent the flu in people who are at higher risk of becoming seriously ill from influenza. Researchers want to find out if MK-1406 dosed at a single study visit can provide protection against influenza compared with placebo. The study will include adolescents and adults who may be more vulnerable to complications from influenza because of their age, health conditions, or weakened immune systems. Researchers will also evaluate the safety of MK-1406 and how well participants tolerate the study medicine.

The 2 groups in the trial

  • MK-1406Treatment being tested

    Participants will receive 450 milligrams (mg) dose of MK-1406 (CD388) by subcutaneous (SC) injection.

  • PlaceboPlacebo, for comparison

    Participants will receive placebo by SC injection.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications
Record updated
13 November 2026